Literature DB >> 22470712

Utility of aortic cuffs in converting initially ineligible patients due to unfavorable neck anatomy into successful candidates for endovascular aortic aneurysm repair: A Case Series.

Omer Awan1, Mark Garcia, Yousaf Awan, Mandip Gakhal, Moonjohn Kim, Bogdan Iliescu, Eliot Siegel.   

Abstract

Endovascular repair of the abdominal aortic aneurysm has been established as a successful alternative to open surgical repair, provided that the criteria necessary for such an approach are fulfilled. Anatomic criteria include suitable diameter, length, and angle of the aneurysm proximal neck. We present three cases in which patients were initially ineligible for endovascular repair because of unfavorable neck anatomy but in whom the use of aortic cuffs allowed for successful endograft placement and aneurysm exclusion.

Entities:  

Keywords:  Aneurysm proximal neck anatomy; Aortic cuff; Endovascular aortic aneurysm repair

Year:  2010        PMID: 22470712      PMCID: PMC3303376          DOI: 10.3941/jrcr.v4i3.344

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  16 in total

1.  Multicenter trial of the PowerLink bifurcated system for endovascular aortic aneurysm repair.

Authors:  Jeffrey P Carpenter
Journal:  J Vasc Surg       Date:  2002-12       Impact factor: 4.268

2.  Results from the Endologix PowerLink multicenter trial.

Authors:  Christopher J Hansen; Ihab Aziz; Benjamin B Kim; Carlos E Donayre; Rodney A White
Journal:  Semin Vasc Surg       Date:  2003-06       Impact factor: 1.000

3.  Aortic neck attachment failure and the AneuRx graft: incidence, treatment options, and early results.

Authors:  Ali Azizzadeh; Luis A Sanchez; Brian G Rubin; Juan C Parodi; Christopher J Godshall; Patrick J Geraghty; Eric T Choi; M Wayne Flye; John A Curci; Gregorio A Sicard
Journal:  Ann Vasc Surg       Date:  2005-07       Impact factor: 1.466

4.  Clinical experience of the use of self-fixing synthetic prostheses for remote endoprosthetics of the thoracic and the abdominal aorta and iliac arteries through the femoral artery and as intraoperative endoprosthesis for aorta reconstruction.

Authors:  N L Volodos; I P Karpovich; V I Troyan; V E Shekhanin; N E Ternyuk; A S Neoneta; N I Ustinov; L F Yakovenko
Journal:  Vasa Suppl       Date:  1991

5.  The correlation of aortic neck length to early and late outcomes in endovascular aneurysm repair patients.

Authors:  Ali F AbuRahma; John Campbell; Patrick A Stone; Aravinda Nanjundappa; Akhilesh Jain; L Scott Dean; Joseph Habib; Tammi Keiffer; Mary Emmett
Journal:  J Vasc Surg       Date:  2009-10       Impact factor: 4.268

6.  A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms.

Authors:  Monique Prinssen; Eric L G Verhoeven; Jaap Buth; Philippe W M Cuypers; Marc R H M van Sambeek; Ron Balm; Erik Buskens; Diederick E Grobbee; Jan D Blankensteijn
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

7.  Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial.

Authors:  R M Greenhalgh; L C Brown; G P S Kwong; J T Powell; S G Thompson
Journal:  Lancet       Date:  2004 Sep 4-10       Impact factor: 79.321

8.  Zenith AAA endovascular graft: intermediate-term results of the US multicenter trial.

Authors:  Roy K Greenberg; Timothy A M Chuter; W Charles Sternbergh; Neal E Fearnot
Journal:  J Vasc Surg       Date:  2004-06       Impact factor: 4.268

9.  Endovascular vs. open repair of abdominal aortic aneurysms in the Medicare population.

Authors:  Marc L Schermerhorn; A James O'Malley; Ami Jhaveri; Philip Cotterill; Frank Pomposelli; Bruce E Landon
Journal:  N Engl J Med       Date:  2008-01-31       Impact factor: 91.245

Review 10.  Food and Drug Administration-approved endovascular repair devices for abdominal aortic aneurysms: a review.

Authors:  Jack Wei Chieh Tan; Khung Keong Yeo; John R Laird
Journal:  J Vasc Interv Radiol       Date:  2008-06       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.